Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
نویسندگان
چکیده
Approximately 240 million people worldwide are chronically infected with hepatitis B virus (HBV), which represents a significant challenge to public health. The current goal in treating chronic HBV infection is to block progression of HBV-related liver injury and inflammation to end-stage liver diseases, including cirrhosis and hepatocellular carcinoma, because we are unable to eliminate chronic HBV infection. Available therapies for chronic HBV infection mainly include nucleos/tide analogues (NAs), non-NAs, and immunomodulatory agents. However, none of them is able to clear chronic HBV infection. Thus, a new generation of anti-HBV drugs is urgently needed. Progress has been made in the development and testing of new therapeutics against chronic HBV infection. This review aims to summarize the state of the art in new HBV drug research and development and to forecast research and development trends and directions in the near future.
منابع مشابه
Latest developments in the treatment of rheumatoid arthritis : is there new hope for patients ?
Over the past decade, treatment of rheumatoid arthritis (RA) has been revolutionized with the introduction of biological disease-modifying antirheumatic drugs (DMARDs), such as TNF inhibitors (e.g., infliximab, etanercept, adalimumab, golimumab and certolizumab pegol), the IL-6 receptor inhibitor tocilizumab, the chimeric anti-CD20 monoclonal antibody rituximab and the T-cell costimulation inhi...
متن کاملPost-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
Background: Viral hepatitis deaths from acute infection, cirrhosis, and liver cancer have risen from the tenth to the seventh leading cause of death worldwide between 1990 and 2013. Even in the oral direct acting antiviral (DAA) agent era there are still large numbers of patients with unmet needs. Medications approved for treatment of chronic hepatitis B virus (HBV) infection do not eradicate H...
متن کاملUnmet Care Needs in Breast Cancer Survivors: An Integrative review
Abstract Introduction: Understanding the unmet care needs of breast cancer survivors is one of the important aspects in healthcare delivery. Objective: This study aimed to identify the unmet needs of breast cancer survivors. Materials & Methods: This Integrative review search of evidence‐based research from five electronic databases (Web of Science, PubMed, Science Direct, Scopus and Google ...
متن کاملProgress of small molecular inhibitors in the development of anti-influenza virus agents
The influenza pandemic is a major threat to human health, and highly aggressive strains such as H1N1, H5N1 and H7N9 have emphasized the need for therapeutic strategies to combat these pathogens. Influenza anti-viral agents, especially active small molecular inhibitors play important roles in controlling pandemics while vaccines are developed. Currently, only a few drugs, which function as influ...
متن کاملProgress and Prospects of Anti-HBV Gene Therapy Development
Despite the availability of an effective vaccine against hepatitis B virus (HBV), chronic infection with the virus remains a major global health concern. Current drugs against HBV infection are limited by emergence of resistance and rarely achieve complete viral clearance. This has prompted vigorous research on developing better drugs against chronic HBV infection. Advances in understanding the...
متن کامل